Isoniazid for preventing tuberculosis in non-HIV infected persons (Q33900621)

29 July 2017

1 reference

title

Isoniazid for preventing tuberculosis in non-HIV infected persons (English)

1 reference

29 July 2017

0 references

0 references

M J Smieja

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6532737&resulttype=core&format=json

14 May 2020

C A Marchetti

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6532737&resulttype=core&format=json

14 May 2020

D J Cook

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6532737&resulttype=core&format=json

14 May 2020

F M Smaill

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6532737&resulttype=core&format=json

14 May 2020

publication date

1 January 2000

1 reference

Cochrane Database of Systematic Reviews

29 July 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6532737&resulttype=core&format=json

14 May 2020

page(s)

CD001363

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6532737&resulttype=core&format=json

14 May 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6532737&resulttype=core&format=json

Prophylaxis with isoniazid in inactive tuberculosis. A Veterans Administration Cooperative Study XII.

14 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001363

Preventive Treatment of Untreated, Nonactive Tuberculosis in an Eskimo Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001363

Prophylactic Effect of Isoniazid in Young Tuberculin Reactors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001363

Isoniazid chemoprophylaxis of latent primary tuberculosis: in five trial centres in France from 1959 to 1969.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001363

A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001363

Tuberculosis in Canadian Eskimos

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001363

Isoniazid preventive therapy for tuberculosis in HIV-1-infected adults: results of a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001363

A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001363

Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001363

Tuberculosis in the 1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001363

Isoniazid Preventive Therapy for Tuberculosis: Decision Analysis Considering Ethnicity and Gender

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001363

The global tuberculosis situation and the new control strategy of the World Health Organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001363

An assessment of clinically useful measures of the consequences of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001363

Using numerical results from systematic reviews in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001363

Monitored isoniazid prophylaxis for low-risk tuberculin reactors older than 35 years of age: a risk-benefit and cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001363

Isoniazid-associated hepatitis deaths: a review of available information

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001363

Benefit-risk considerations in preventive treatment for tuberculosis in elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001363

A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001363

The chemoprophylaxis of tuberculosis in Gurkha soldiers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001363

Ten year evaluation of a trial of chemoprophylaxis against tuberculosis in Frobisher Bay, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001363

Prophylactic isoniazid: protection of infants in a tuberculosis hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001363

Prophylactic isoniazid in nurses in a tuberculosis hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001363

Isoniazid in the prevention and treatment of tuberculosis. A 20-year study of the effectiveness in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001363

Thirty years after isoniazid. Its impact on tuberculosis in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001363

EFFECT OF ISONIAZID UPON THE REACTIVATION OF INACTIVE TUBERCULOSIS; FINAL REPORT

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001363

Preventive effects of isoniazid in the treatment of primary tuberculosis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001363

Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001363

Antituberculous chemoprophylaxis with isoniazid preliminary note

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001363

Further developments in human and bovine anti-tuberculosis chemoprophylaxis with isoniazid in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001363

A cost-effectiveness analysis of the routine use of isoniazid prophylaxis in patients with a positive Mantoux skin test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001363

Control and prevention of tuberculosis in Britain: an updated code of practice. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001363

Control and prevention of tuberculosis in the United Kingdom: Code of Practice 1994. Joint Tuberculosis Committee of the British Thoracic Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001363

Chemotherapy and management of tuberculosis in the United Kingdom: recommendations of the Joint Tuberculosis Committee of the British Thoracic Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001363

Decision analysis for isoniazid preventive therapy: take it or leave it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001363

Should Young Adults with a Positive Tuberculin Test Take Isoniazid?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001363

Prophylactic effects of isoniazid on primary tuberculosis in children; a preliminary report

21 January 2018

1 reference

12 December 2020

Prophylactic treatment of tuberculous contacts: a preliminary report

1 reference

12 December 2020

The immediate effectiveness of isoniazid chemoprophylaxis as determined by the tuberculin test. A five-year study including 5,555 Navajo and Pueblo children from birth to 15 years of age and the use of isonicotinic acid hydrazide in the prevention o

1 reference

12 December 2020

Mass chemoprophylaxis of tuberculosis. The acceptability and untoward side effects of isoniazid in a control study in Greenland

1 reference

12 December 2020

Tuberculosis morbidity in a controlled trial of the prophylactic use of isoniazid among household contacts

1 reference

12 December 2020

Isoniazid prophylaxis in an undeveloped area

1 reference

12 December 2020

A CONTROLLED TRIAL OF ISONIAZID PROPHYLAXIS IN MENTAL INSTITUTIONS.

1 reference

12 December 2020

CHEMOPROPHYLAXIS OF PRIMARY TUBERCULOSIS IN CHILDREN AND ADOLESCENTS IN FRANCE: AN EPIDEMIOLOGICAL STUDY OF CASES RECRUITED FROM 1948 TO 1958 AND FOLLOWED UP TO 1963

1 reference

12 December 2020

CHEMOPROPHYLAXIS OF TUBERCULOSIS FOR ADULTS IN JAPAN

1 reference

12 December 2020

Effect of isoniazid upon the reactivation of inactive tuberculosis. Preliminary report

1 reference

12 December 2020

The effect of isoniazid prophylaxis on tuberculosis morbidity among household contacts of previously known cases of tuberculosis

1 reference

12 December 2020

American Academy of Pediatrics Committee on Infectious Diseases: Chemotherapy for tuberculosis in infants and children

1 reference

12 December 2020

The use of preventive therapy for tuberculous infection in the United States. Recommendations of the Advisory Committee for Elimination of Tuberculosis

1 reference

12 December 2020

Preventive therapy with isoniazid. Cost-effectiveness of different durations of therapy

1 reference

12 December 2020

The age threshold for isoniazid chemoprophylaxis. A decision analysis for low-risk tuberculin reactors

1 reference

12 December 2020

Isoniazid prophylaxis among Alaskan Eskimos: a progress report.

1 reference

12 December 2020

Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies

1 reference

12 December 2020

Efficacy of bacillus Calmette-Guérin and isoniazid-resistant bacillus Calmette-Guérin with and without isoniazid chemoprophylaxis from day of vaccination. II. Field trial in man

1 reference

12 December 2020

Long-term results of the chemoprophylactic trial in Greenland

1 reference

12 December 2020

Long term isoniazid prophylaxis. Controlled trial on INH prophylaxis after recent tuberculin conversion in young adults

1 reference

12 December 2020

Controlled chemoprophylaxis trials in tuberculosis. A general review

1 reference

12 December 2020

Effects of chemoprophylaxis on minimal pulmonary tuberculosis lesions of doubtful activity

1 reference

12 December 2020

Isoniazid prophylaxis in a slum area

1 reference

12 December 2020

Feasibility of a chemoprophylaxis trial in India against tuberculosis. A pilot study

1 reference

12 December 2020

Isoniazid prophylaxis in contacts of persons with known tuberculosis. Second report

1 reference

12 December 2020

The use of isoniazid among household contacts of open cases of pulmonary tuberculosis

1 reference

12 December 2020

Epidemiological basis of tuberculosis eradication. 4. The isoniazid trial in Greenland

1 reference

12 December 2020

Isoniazid prophylaxis in Alaskan Boarding schools. A comparison of two doses

1 reference

12 December 2020

An appraisal of the chemoprophylaxis of tuberculosis in the student population of Lublin, Poland, following thirty months' observation

1 reference

12 December 2020

A controlled trial of community-wide isoniazid prophylaxis in Alaska

1 reference

12 December 2020

1 reference

12 December 2020

Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. International Union Against Tuberculosis Committee on Prophylaxis

1 reference

12 December 2020

A double-blind randomized controlled trial of primary isoniazid prophylaxis in dialysis and transplant patients

1 reference

12 December 2020

The IUAT trial on isoniazid preventive treatment in persons with fibrotic lung lesions

1 reference

12 December 2020

Chemoprophylaxis in inactive tuberculosis: long-term evaluation of a Canadian trial

1 reference

12 December 2020

Preventive therapy for tuberculosis

1 reference

12 December 2020

Fatal isoniazid-induced hepatitis. Its risk during chemoprophylaxis

1 reference

12 December 2020

10.1002/14651858.CD001363

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6532737&resulttype=core&format=json

release_3jjrdciawnd3vet2c7mc5e235i

14 May 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3jjrdciawnd3vet2c7mc5e235i

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6532737&resulttype=core&format=json

14 May 2020

1 reference